Better Choice CO INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
SRx Health Solutions, Inc. has secured majority shareholder approval for significant capital raises, an increase in authorized shares, a reduction in shareholder meeting quorum, and an additional reverse stock split.
SRx Health Solutions, Inc. announces a board-approved reverse stock split ranging from 15-to-1 to 60-to-1 to maintain NYSE American listing and enhance capital flexibility.
Better Choice Company Inc. supplements its proxy statement with details on a potential acquisition of Choice Specialty Pharmacy Group and an SRx debt conversion, while also extending the outside date for its arrangement agreement.
Better Choice Company Inc. will acquire SRx Health Solutions Inc. in an all-stock transaction, pending shareholder and regulatory approvals.
Better Choice Company Inc. will hold its annual meeting of stockholders on December 18, 2024, to vote on the election of directors, executive compensation, the appointment of an independent registered public accountant, and other business matters.
Better Choice Company is implementing a reverse stock split, with a ratio between 1-for-25 and 1-for-45, to meet NYSE American listing requirements and enhance the appeal of its common stock.